Skip to main content
SpringerLink
Log in

Adrenal Medullary Dysfunction

  • Chapter
  • First Online:
Adrenal Imaging

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 1096 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stenstrom G, Svardsudd K (1986) Phaechromocytoma in Sweden, 1958-81. An analysis of the National Cancer Registry Data. Acta Med Scand 220:225–232

    Article  PubMed  CAS  Google Scholar 

  2. Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. Am J Roentgenol 185:684–688

    Google Scholar 

  3. Young WF Jr (2007) The incidentally discovered adrenal mass. N Engl J Med 356(6):601–610

    Article  PubMed  CAS  Google Scholar 

  4. Young WF Jr, Maddox DE (1995) Spells: in search of a cause. Mayo Clin Proc 70:757–765

    Article  PubMed  Google Scholar 

  5. Neumann HP, Bausch B, McWhinney SR et al. (2002) Germ-line mutations in nonsyndromeic pheochromocytoma. N Engl J Med 346:1459–1466

    Article  PubMed  CAS  Google Scholar 

  6. Kudva YC, Sawka AM, Young WF Jr (2003) Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 88:4533–4539

    Article  PubMed  CAS  Google Scholar 

  7. Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol 66:703–708

    Article  CAS  Google Scholar 

  8. d'Herbomez M, Forzy G, Bauters C et al. (2007) An analysis of the biochemical diagnosis of 66 pheochromocytomas. Eur J Endocrinol 156(5):569–575

    Article  PubMed  Google Scholar 

  9. Young WF Jr (1993) Pheochromocytoma: 1926-1993. Trends Endocrinol Metab 4:122–127

    Article  PubMed  Google Scholar 

  10. Lenders JW, Pacak K, Walther MM et al. (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427–1434

    Article  PubMed  CAS  Google Scholar 

  11. Sawka AM, Prebtani AP, Thabane L et al. (2004) A systematic review of the literature examining the diagnostic efficacy of measurement of fractionate plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endorc Disord 4:2

    Google Scholar 

  12. van Gils APG, Falke THM, van Erkel AR et al (1991) MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics 11:37–57

    PubMed  Google Scholar 

  13. Shapiro B, Gross MD, Fig L et al. (1990) Localization of functioning sympathoadrenal lesions. In: Biglieri EG, Melby JC (eds) Endocrine hypertension. Raven Press, New York, pp 235–255

    Google Scholar 

  14. Jalil ND, Pattou FN, Combemale F et al. (1998) Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC) and The French Association of Endocrine Surgeons (AFCE). Eur J Surg 164:23–28

    Article  PubMed  CAS  Google Scholar 

  15. Miskulin J, Shulkin BL, Doherty GM et al. (2003) Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134:918–922

    Article  PubMed  Google Scholar 

  16. Taieb D, Sebag F, Hubbard JG et al. (2004) Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Clin Endocrinol (Oxf) 61:102–108

    Article  CAS  Google Scholar 

  17. Bravo EL (2002) Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci 970:1–10

    Article  PubMed  CAS  Google Scholar 

  18. Combemale F, Carnaille B, Tavernier B et al. (1998) Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. 70 cases. Ann Chir 52:341–345

    PubMed  CAS  Google Scholar 

  19. Lebuffe G, Dosseh ED, Tek G et al. (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 60:439–444

    Article  PubMed  CAS  Google Scholar 

  20. Memtsoudis SG, Swamidoss C, Psoma M (2005) Anesthesia for adrenal surgery. In: Linos D, van Heerden JA (eds) Adrenal glands: diagnostic aspects and surgical therapy. Springer, Berlin Heidelberg New York, pp 287–297

    Google Scholar 

  21. Plouin PF, Duclos JM, Soppelsa F et al. (2001) Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 86:1480–1486

    Article  PubMed  CAS  Google Scholar 

  22. Hack HA (2000) The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 10:463–476

    Article  PubMed  CAS  Google Scholar 

  23. Reddy VS, O'Neill JA Jr, Holcomb GW III et al. (2000) Twenty-five-year surgical experience with pheochromocytoma in children. Am Surg 66:1085–1091

    PubMed  CAS  Google Scholar 

  24. Grant C (2005) Pheochromocytoma. In: Clark O, Duh Q-Y, Kebebew E (eds) Textbook of endocrine surgery. Elsevier Saunders, Philadelphia, pp 621–633

    Google Scholar 

  25. Shen WT, Sturgeon C, Clark OH et al. (2004) Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery 136:1129–1137

    Article  PubMed  Google Scholar 

  26. Lee JE, Curley SA, Gagel RF et al. (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064–1071

    Article  PubMed  CAS  Google Scholar 

  27. Walther MM, Keiser HR, Choyke PL et al. (1999) Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 161:395–398

    Article  PubMed  CAS  Google Scholar 

  28. Diner EK, Franks ME, Behari A, Linehan WM, Walther MM (2005) Partial adrenalectomy: the National Cancer Institute experience. Urology 66(1):19–23

    Article  PubMed  Google Scholar 

  29. Amar L, Servais A, Gimeniz-Roqueplo AP et al. (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110–2116

    Article  PubMed  CAS  Google Scholar 

  30. Pawlu C, Bausch B, Reisch N, Neumann HP (2005) Genetic testing for pheochromocytoma-associated syndromes. Ann Endocrinol (Paris) 66:178–185

    Article  CAS  Google Scholar 

  31. Sisson JC (2002) Radiopharmaceutical treatment of pheochromocytomas. Ann N Y Acad Sci 970:54–60

    Article  PubMed  CAS  Google Scholar 

  32. Safford SD, Coleman RE, Gockerman JP et al. (2003) Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 134:956–962

    Article  PubMed  Google Scholar 

  33. Rose B, Matthay KK, Price D et al. (2003) High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 98:239–248

    Article  PubMed  CAS  Google Scholar 

  34. Loh KC, Fitzgerald PA, Matthay KK et al. (1997) The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20:648–658

    PubMed  CAS  Google Scholar 

  35. Averbuch SD, Steakley CS, Young RC et al. (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109:267–273

    PubMed  CAS  Google Scholar 

  36. Eisenhofer G, Bornstein SR, Brouwers FM et al. (2004) Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11:423–436

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic Rochester, 200 First Street S.W, Rochester, MN 55905

    William F. Young Jr MD, MSc

Authors
  1. William F. Young Jr MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William F. Young Jr MD, MSc .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Dept. Radiology, Harvard Medical School, Fruit St. 55, Boston, 02114, U.S.A.

    Michael A. Blake

  2. Massachusetts General Hospital, Dept. Radiology, Harvard Medical School, Fruit St. 55, Boston, 02114, U.S.A.

    Giles Boland

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Young, W.F. (2009). Adrenal Medullary Dysfunction. In: Blake, M., Boland, G. (eds) Adrenal Imaging. Contemporary Medical Imaging. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-560-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-560-2_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-934115-86-2

  • Online ISBN: 978-1-59745-560-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation